Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Program: Scientific Workshops
Session: DDX41-Mediated Malignancies
Program: Scientific Workshops
Session: DDX41-Mediated Malignancies
Friday, December 6, 2024, 2:41 PM-3:25 PM
Disclosures: Gronbaek: Janssen: Research Funding; Otsuka Pharma: Membership on an entity's Board of Directors or advisory committees.
See more of: DDX41-Mediated Malignancies
See more of: Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
See more of: Scientific Workshops
See more of: Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
See more of: Scientific Workshops